Vanderstichele H, De Vreese K, Blennow K, Andreasen N, Sindic C, Ivanoiu A, Hampel H, Bürger K, Parnetti L, Lanari A, Padovani A, DiLuca M, Bläser M, Olsson AO, Pottel H, Hulstaert F, Vanmechelen E. Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies. Clin Chem Lab Med. 2006;44(12):1472-80. PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : Aβ42 (CSF)
- CTRL vs AD : Aβ42 (CSF)
- DLB vs AD : Aβ42 (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- DLB vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
- DLB vs AD : tau-total (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ42 (CSF) |
AD (94) |
403.3 ± 160.8 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
Aβ42 (CSF) |
CTRL- Other Controls (60) |
719.2 ± 303.2 pg/mL |
ELISA; Innotest; Innogenetics |
|
Aβ42 (CSF) |
DLB (60) |
454.8 ± 177.1 pg/mL |
ELISA; Innotest; Innogenetics |
McKeith et al., 1996 |
tau-p181 (CSF) |
AD (94) |
84.5 ± 38.1 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
CTRL- Other Controls (60) |
44.2 ± 16.2 pg/mL |
ELISA; Innotest; Innogenetics |
|
tau-p181 (CSF) |
DLB (60) |
49.8 ± 22.5 pg/mL |
ELISA; Innotest; Innogenetics |
McKeith et al., 1996 |
tau-total (CSF) |
AD (94) |
648.8 ± 342.1 pg/mL |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- Other Controls (60) |
226.6 ± 125.2 pg/mL |
ELISA; Innotest; Innogenetics |
|
tau-total (CSF) |
DLB (60) |
326.8 ± 241.7 pg/mL |
ELISA; Innotest; Innogenetics |
McKeith et al., 1996 |
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.